Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALLO | TVTX | FATE | ||
| Company | Allogene Therapeutics Inc | Travere Therapeutics Inc | Fate Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.79 | 6.34 | 4.09 | ||
| High | 2.95 | 6.56 | 4.54 | ||
| Low | 2.79 | 6.25 | 4.09 | ||
| Last | 2.91 | 6.28 | 4.28 | ||
| Change | +0.15 | -0.02 | +0.20 | ||
| % Change | +5.43% | -0.32% | +4.90% | ||
| Volume | 339,538 | 216,467 | 1,394,908 | ||
| 20-Day Average Volume | 1,723,169 | 1,306,287 | 3,019,633 | ||
| Previous Close | 2.76 | 6.30 | 4.08 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.06 | 6.00 | 4.30 | ||
| 20-Day Raw Stochastic | 20.43% | 45.53% | 32.18% | ||
| 20-Day Relative Strength | 37.00% | 45.72% | 39.71% | ||
| Weighted Alpha | -54.03 | -52.43 | -43.66 | ||
| Today's Opinion | 40% Sell | 72% Sell | 8% Sell | ||
| Previous Opinion | 40% Sell | 72% Sell | 8% Sell | ||
| Last Month's Opinion | 8% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.99% since 05/06/24 | -3.97% since 05/06/24 | +1.30% since 05/06/24 | ||
| Low | 2.74 on 05/10/24 | 6.26 on 05/13/24 | 3.58 on 05/08/24 | ||
| High | 3.07 on 05/07/24 | 7.69 on 05/07/24 | 4.54 on 05/13/24 | ||
| 1-Month | |||||
| %Chg | -23.95% since 04/12/24 | -1.26% since 04/12/24 | -25.91% since 04/12/24 | ||
| Low | 2.70 on 04/30/24 | 5.12 on 04/25/24 | 3.58 on 05/08/24 | ||
| High | 3.88 on 04/15/24 | 7.69 on 05/07/24 | 5.95 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | -37.31% since 02/13/24 | -21.28% since 02/13/24 | -33.10% since 02/13/24 | ||
| Low | 2.70 on 04/30/24 | 5.12 on 04/25/24 | 3.58 on 05/08/24 | ||
| High | 5.78 on 03/08/24 | 9.03 on 03/08/24 | 8.83 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | +19.42% since 11/13/23 | +10.35% since 11/13/23 | +114.82% since 11/13/23 | ||
| Low | 2.23 on 12/01/23 | 5.12 on 04/25/24 | 2.05 on 11/14/23 | ||
| High | 5.78 on 03/08/24 | 10.27 on 01/10/24 | 8.83 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 471,196 | 479,613 | 464,373 | ||
| Shares Outstanding, K | 170,723 | 76,129 | 113,817 | ||
| Annual Sales | 100,000 | 145,240,000 | 63,530,000 | ||
| Annual Net Income | -327,270,000 | -111,400,000 | -160,930,000 | ||
| Last Quarter Sales | 40,000 | 37,100,000 | 1,680,000 | ||
| Last Quarter Net Income | -61,320,000 | 150,740,000 | -44,120,000 | ||
| 60-Month Beta | 0.90 | 0.69 | 1.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.43 on 03/14/24 | -1.76 on 05/06/24 | -0.45 on 02/26/24 | ||
| Latest Earnings Date | 05/13/24 | 05/06/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||